Abstract | OBJECTIVES: Medical treatment of non- atypical endometrial hyperplasia with oral progestogens has limited efficacy and poor compliance. A levonorgestrel-releasing intrauterine system (LNG-IUS) has been shown to successfully treat hyperplasia in small-sized studies. Our aim was to examine the effectiveness of LNG-IUS in a larger study with long-term follow up. STUDY DESIGN: Prospective observational study of 105 women diagnosed with endometrial hyperplasia and treated with LNG-IUS between 1999 and 2004 at a University Teaching hospital. Baseline characteristics and outpatient endometrial Pipelle sampling were undertaken at 3 and 6 months post LNG-IUS insertion and 6-monthly intervals thereafter in all cases. Outcome included histological data derived from both Pipelle and uterine histologies at 1 and 2 years LNG-IUS therapy. RESULTS: LNG-IUS achieved endometrial regression in 90% (94/105) of cases by 2 years, with a significant proportion (96%, 90/94) achieving this within 1 year. Regression occurred in 88/96 (92%) of non-atypical and 6/9 (67%) of atypical hyperplasias, and in all 22 cases of endometrial hyperplasia associated with HRT. Regression rates did not differ between histological types of hyperplasia. Twenty-three women (22%) underwent hysterectomy of which 13 were indicated and 10 were performed at patient request despite regressed endometrium. Two cases of cancer (one uterine and one ovarian) were identified. CONCLUSION: LNG-IUS is highly effective in treating endometrial hyperplasia. Beneficial effects are observed by the majority within 1 year. Treatment can be reliably monitored through regular 6-montly outpatient endometrial Pipelle surveillance. LNG-IUS treatment of non-atypical hyperplasias is likely to reduce the number of hysterectomies performed in this subgroup.
|
Authors | Rajesh Varma, Hemi Soneja, Kalsang Bhatia, Raji Ganesan, Terence Rollason, T Justin Clark, Janesh K Gupta |
Journal | European journal of obstetrics, gynecology, and reproductive biology
(Eur J Obstet Gynecol Reprod Biol)
Vol. 139
Issue 2
Pg. 169-75
(Aug 2008)
ISSN: 0301-2115 [Print] Ireland |
PMID | 18440693
(Publication Type: Journal Article)
|
Chemical References |
- Contraceptive Agents, Female
- Progestins
- Levonorgestrel
|
Topics |
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Contraceptive Agents, Female
(administration & dosage)
- Endometrial Hyperplasia
(drug therapy)
- Female
- Follow-Up Studies
- Humans
- Hysterectomy
- Intrauterine Devices, Medicated
- Levonorgestrel
(administration & dosage)
- Longitudinal Studies
- Middle Aged
- Progestins
(administration & dosage, therapeutic use)
- Treatment Outcome
|